Research projects must be hypothesis-driven, breast cancer-focused studies. They may be considered basic, translational, clinical and/or population science in nature and should align with Komen’s research priorities and mission to save lives from breast cancer. Komen’s research priorities are conquering metastatic and aggressive breast cancers, advancing personalized breast cancer care throughout the continuum of care, and improving health outcomes for everyone impacted by breast cancer. Metastatic breast cancer-focused studies may include, but are not limited to, the development of novel treatment strategies for existing metastatic disease, strategies to prevent or arrest metastasis and late recurrence, and innovative approaches to detect new or recurrent metastatic breast cancer. See guidelines for more details.

Managing Unit: SCI (Stanford Cancer Institute)